Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic

Takeaways

The main points, in the order they come up. Tap a time to play from there.

1. 0:00 Novo Nordisk agreed to sell Wegovy and Ozempic through the Hims and Hers telehealth platform, ending a dispute over a $49 compounded alternative to the Wegovy pill.
2. 0:00 The report says Hims shares rose as much as 49% in morning trading after the announcement.
3. 0:30 Hims will offer FDA-approved Ozempic and Wegovy injectables and the Wegovy pill with no increase in price, according to the video.
4. 0:30 Hims will stop advertising compounded GLP-1 drugs but will still provide them when providers deem it clinically necessary.
5. 0:30 The video says Novo cut prices on its websites from about $1,000 per month to under $300 amid competition from Eli Lilly.
6. 1:00 Novo said the Wegovy pill has generated more than 600,000 prescriptions in 2 months, helped by telehealth partnerships.

Key moments

From the creator's own chapters. Tap one to play from there.

1. 0:00 Novo Nordisk and Hims deal
2. 0:20 Market impact and competition
3. 0:33 Agreement terms
4. 0:55 Price cuts and demand

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication

Ozempic and Wegovy

Who is speaking

News or media

Read next

Our guides closest to what this video covers, with prices checked weekly.

• Wegovy vs Ozempic: the same drug, and why the box still decides what you pay

  Wegovy and Ozempic are both semaglutide from Novo Nordisk. The difference is the label: Ozempic is approved for type 2 diabetes and tops out at 2 mg a week; Wegovy is approved for weight loss and goes to 2.4 mg, or 7.2 mg in the HD pen. Both now come as a daily pill as well. The label decides whether a plan pays and what cash costs: direct from Novo, both pens are $349 a month up to 1 mg, and Ozempic 2 mg is $499.

• The Wegovy pill: what each dose costs, and how it compares with the pen

  Wegovy is now sold as a daily tablet as well as a weekly injection, and the tablet self-pays cheaper. Novo's published prices run $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg. The $149 offer on 4 mg ended on 31 August 2026. There are also three different semaglutide pills on the market now, which is the thing most pages about this have not caught up with.

• Generic Ozempic: none in the US until December 2031, where generics already sell, and what to buy instead

  No. There is no FDA-approved generic Ozempic or Wegovy in the US, and the FDA Orange Book lists Novo Nordisk's semaglutide compound patent until 5 December 2031. Generics went on sale in India in March 2026 and in Canada in May, but a US buyer cannot legally import them. What you can buy today: compounded semaglutide from $69 a month on our board, or Novo's own self-pay Wegovy at $349 a month for the pen and from $149 for the pill.

Find more like it

Cost and insurance